WuXi XDC Cayman Inc.
Research WuXi XDC Cayman Inc. (L74) on Bullrun: market cap EUR 8.22B, P/E 45.7. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerL74
- ExchangeF
- CountryChina
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyEUR
- Market capEUR 8.22B
- P/E45.7
- Financial periodFY2025
- RevenueEUR 5.94B
- Revenue growth46.7%
- Net incomeEUR 1.48B
- Free cash flowEUR 523.52M
- Gross margin36.0%
Valuation Snapshot
latest market cap is EUR 8.22B; P/E is 45.7.
About WuXi XDC Cayman Inc.
WuXi XDC Cayman Inc., an investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally. It engages in the discovery, research, development, and manufacture of the drug substances and drug products of antibody drug conjugates, bioconjugates, monoclonal antibody intermediates, and payload-linkers associated with bioconjugates. It also provides international sales contracting services.
Frequently asked questions
What is WuXi XDC Cayman Inc.'s market cap?
WuXi XDC Cayman Inc.'s market capitalization is EUR 8.22B.
What is WuXi XDC Cayman Inc.'s P/E ratio?
WuXi XDC Cayman Inc.'s price-to-earnings (P/E) ratio is 45.7.
What does WuXi XDC Cayman Inc. do?
WuXi XDC Cayman Inc., an investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.